| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 25mg |
|
||
| 100mg |
|
||
| 250mg | |||
| Other Sizes |
| ln Vitro |
- Maltopentaose was used as a substrate in an in vitro study to investigate the glycation and phosphorylation of α-lactalbumin. It participated in the non-enzymatic glycation reaction with α-lactalbumin under experimental conditions, enabling the analysis of the modified protein's properties [1]
- The interaction between Maltopentaose and α-lactalbumin facilitated the investigation of how oligosaccharide chain length affects protein glycation and phosphorylation efficiency [1] |
|---|---|
| References | |
| Additional Infomation |
Maltopentose is a pentasaccharide in which the glucose residue at the reducing end exists in an open-chain aldehyde form. Maltopentose is a metabolite found in or produced by Escherichia coli (K12 strain, MG1655 strain).
It has been reported that (2R,3R,4R,5R)-4-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxecyclohexane-2-yl]oxecyclohexane-2-yl]oxecyclohexane-3,4-dihydroxy-6-(hydroxymethyl)oxecyclohexane-2-yl]oxecyclohexane-3,4-dihydroxy-6-(hydroxymethyl)oxecyclohexane-2-yl]oxecyclohexane-2,3,5,6-tetrahydroxyhexanal exists in the fruit fly (Drosophila melanogaster), and related data have been published. - Maltopentose is an oligosaccharide composed of five glucose units linked together. α-1,4 glycosidic bond[1] - It is defined as the shortest chain oligosaccharide that can be classified as maltodextrin[1] - This study selected this compound as a model oligosaccharide to explore the structural and functional changes of α-lactalbumin after glycosylation and phosphorylation, so as to gain a deeper understanding of the effects of oligosaccharide modification on protein properties[1] |
| Molecular Formula |
C30H52O26
|
|---|---|
| Molecular Weight |
828.7183
|
| Exact Mass |
788.243
|
| CAS # |
34620-76-3
|
| PubChem CID |
124005
|
| Appearance |
White to off-white solid powder
|
| Density |
1.9±0.1 g/cm3
|
| Boiling Point |
1248.9±65.0 °C at 760 mmHg
|
| Flash Point |
709.1±34.3 °C
|
| Vapour Pressure |
0.0±0.6 mmHg at 25°C
|
| Index of Refraction |
1.697
|
| LogP |
-4.06
|
| Hydrogen Bond Donor Count |
17
|
| Hydrogen Bond Acceptor Count |
26
|
| Rotatable Bond Count |
17
|
| Heavy Atom Count |
56
|
| Complexity |
1190
|
| Defined Atom Stereocenter Count |
24
|
| SMILES |
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)O)O)CO)CO)CO)O)O)O)O
|
| InChi Key |
FJCUPROCOFFUSR-GMMZZHHDSA-N
|
| InChi Code |
InChI=1S/C30H52O26/c31-1-7(37)13(39)23(8(38)2-32)53-28-20(46)16(42)25(10(4-34)50-28)55-30-22(48)18(44)26(12(6-36)52-30)56-29-21(47)17(43)24(11(5-35)51-29)54-27-19(45)15(41)14(40)9(3-33)49-27/h1,7-30,32-48H,2-6H2/t7-,8+,9+,10+,11+,12+,13+,14+,15-,16+,17+,18+,19+,20+,21+,22+,23+,24+,25+,26+,27+,28+,29+,30+/m0/s1
|
| Chemical Name |
(2R,3R,4R,5R)-4-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanal
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ~125 mg/mL (~150.84 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (120.67 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
(Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.2067 mL | 6.0334 mL | 12.0668 mL | |
| 5 mM | 0.2413 mL | 1.2067 mL | 2.4134 mL | |
| 10 mM | 0.1207 mL | 0.6033 mL | 1.2067 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
